Insider Title Company Date Price Return Shares Value
Blume-Jensen Peter President and CEO Acrivon Therapeutics, Inc. (ACRV) 2026-01-14 $1.68 0.0% 49,000 $82,124
Return Profit / (loss) Cost
Total 0.0% $0 $82,124